A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial.

By P. Lips, T. Duong, A. Oleksik, D. Black, Steve Cummings, David G. Cox, T. Nickelsen. Journal of Clinical Endocrinology and Metabolism, 2001

778 citations recorded by the source corpus.

Subfields: Genetics, Orthopedics and Sports Medicine, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/4ce22a1c28f1cc9809e51dc2346aefba8c552887

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Genetics

In Orthopedics and Sports Medicine

In Pathology and Forensic Medicine

Citations in the corpus

Vitamin D physiology. (2006, background): “Within Europe, serum 25(OH)D is positively related to latitude, contrary to what should be expected (Lips et al., 2001).”
Global vitamin D status and determinants of hypovitaminosis D (2009, methodology): “serum 25(OH)D and latitude was found in the baseline data of the Multiple Outcomes of Raloxifene Evaluation (MORE) study, a clinical trial on the effect of raloxifene in postmenopausal women with osteoporosis, which also used a central laboratory facility [ 55 ].”
Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. (2006, background): “Thus, optimal fracture prevention may require intakes of 700–800 IU vitamin D/d in populations with baseline 25(OH)D concentrations 44 nmol/L, and baseline concentrations may depend on latitude (44), type of dwelling FIGURE 1.”
Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. (2001, background): “The decrease of serum PTH was 18%, 12%, or 4% depending on baseline 25(OH)D lower than 25 nmol/liter, 25–50 nmol/liter, or higher than 50 nmol/liter, respectively (189).”
Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. (2003, background): “should be 50 nmol/liter (59, 60) or as high as 76–90 nmol/”
Estimates of optimal vitamin D status (2005, background): “It is generally recognized that the increment in serum 25(OH)D in response to a given oral dose of vitamin D3 is inversely related to the starting level of 25(OH)D [3, 32].”
Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. (2005, result): “The prevalence in our study was consistent with the results of a previously reported multinational osteoporosis study (13).”